tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IMCR Stock Latest News

Immunocore price target lowered to $33 from $38 at Mizuho
The FlyImmunocore price target lowered to $33 from $38 at Mizuho
28d ago
IMCR
Immunocore Holdings: Buy Rating Backed by Promising Strategy and Strong Financials Despite Mixed Study Data
PremiumRatings
Immunocore Holdings: Buy Rating Backed by Promising Strategy and Strong Financials Despite Mixed Study Data
2M ago
IMCR
Immunocore Holdings’ Promising HIV Immunotherapy Advances Justify Buy Rating
PremiumRatings
Immunocore Holdings’ Promising HIV Immunotherapy Advances Justify Buy Rating
2M ago
IMCR
Positive Outlook on Immunocore Holdings’ Innovative HIV Program Justifies Buy Rating
PremiumRatings
Positive Outlook on Immunocore Holdings’ Innovative HIV Program Justifies Buy Rating
2M ago
IMCR
Immunocore Holdings Reveals Promising HIV Trial Results
PremiumCompany Announcements
Immunocore Holdings Reveals Promising HIV Trial Results
2M ago
8K
IMCR
Immunocore assumed with an Equal Weight at Morgan Stanley
PremiumThe FlyImmunocore assumed with an Equal Weight at Morgan Stanley
2M ago
IMCR
Immunocore Holdings: Pioneering HIV Cure with Promising Phase 1 STRIVE Trial Results
Premium
Ratings
Immunocore Holdings: Pioneering HIV Cure with Promising Phase 1 STRIVE Trial Results
2M ago
IMCR
Immunocore Reports 2024 Growth and Strategic Advances
Premium
Company Announcements
Immunocore Reports 2024 Growth and Strategic Advances
2M ago
IMCR
Immunocore’s Strategic Expansion and Robust Pipeline Drive Buy Rating
PremiumRatings
Immunocore’s Strategic Expansion and Robust Pipeline Drive Buy Rating
2M ago
IMCR
Immunocore Holdings: Positive Earnings Call Highlights Growth
PremiumCompany Announcements
Immunocore Holdings: Positive Earnings Call Highlights Growth
2M ago
IMCR
Immunocore price target lowered to $85 from $88 at Oppenheimer
PremiumThe Fly
Immunocore price target lowered to $85 from $88 at Oppenheimer
2M ago
IMCR
Immunocore Holdings: Strong KIMMTRAK Performance and Promising Pipeline Justify Buy Rating
PremiumRatings
Immunocore Holdings: Strong KIMMTRAK Performance and Promising Pipeline Justify Buy Rating
2M ago
IMCR
Immunocore Holdings Faces Trade Secret Challenges Amid Global Competition
PremiumCompany AnnouncementsImmunocore Holdings Faces Trade Secret Challenges Amid Global Competition
2M ago
IMCR
Immunocore Holdings: Strong Kimmtrak Sales and Promising Pipeline Support Buy Rating
Premium
Ratings
Immunocore Holdings: Strong Kimmtrak Sales and Promising Pipeline Support Buy Rating
2M ago
IMCR
Immunocore Holdings: Sustained Growth and Promising Pipeline Drive Positive Outlook
Premium
Ratings
Immunocore Holdings: Sustained Growth and Promising Pipeline Drive Positive Outlook
2M ago
IMCR
Immunocore Holdings Appoints William Pao as Director
PremiumCompany Announcements
Immunocore Holdings Appoints William Pao as Director
2M ago
8K
IMCR
Immunocore reports Q4 EPS (47c), consensus (16c)
PremiumThe Fly
Immunocore reports Q4 EPS (47c), consensus (16c)
2M ago
IMCR
IMCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
IMCR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
IMCR
Immunocore Holdings Outlines Strategic Priorities for 2025
PremiumCompany Announcements
Immunocore Holdings Outlines Strategic Priorities for 2025
4M ago
8K
IMCR
Immunocore reports cash, equivalents of $820M as of December 31
PremiumThe FlyImmunocore reports cash, equivalents of $820M as of December 31
4M ago
IMCR
Immunocore announces 2025 strategic priorities at JPM Conference
Premium
The Fly
Immunocore announces 2025 strategic priorities at JPM Conference
4M ago
IMCR
Immunocore Holdings Strengthens Leadership with Key Appointment
Premium
Company Announcements
Immunocore Holdings Strengthens Leadership with Key Appointment
4M ago
8K
IMCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >